Edition:
United States

CanniMed Therapeutics Inc (CMED.TO)

CMED.TO on Toronto Stock Exchange

30.77CAD
4:00pm EDT
Change (% chg)

$-2.03 (-6.19%)
Prev Close
$32.80
Open
$32.81
Day's High
$32.81
Day's Low
$30.77
Volume
13,755
Avg. Vol
384,843
52-wk High
$46.00
52-wk Low
$7.32

Summary

Name Age Since Current Position

Andre Jerome

2018 Interim Chief Executive Officer, Director

John Knowles

61 2008 Chief Financial Officer, Corporate Secretary, Director

Gulwant Bajwa

54 Vice President - Business Development and Regulatory Affairs

Larry Holbrook

69 Chief Research Officer

Michael Dowty

2018 Director

Michel Lamontagne

2018 Director

Douglas Banzet

66 2001 Independent Director

Rob Duguid

52 2001 Independent Director

Biographies

Name Description

Andre Jerome

Mr. Andre Jerome is Interim Chief Executive Officer, Director of the Company. Mr. Jerome is senior vice-president of business integration at Aurora, where he is responsible for the integration of acquisitions, as well as for the identification of potential synergies across existing subsidiaries and joint venture partners. Mr. Jerome, a member of the Bar of Quebec for the last 23 years, joined Aurora from H2 Biopharma Inc., where he was chief executive officer and co-founder. Mr. Jerome was already tasked with heading up the integration of CanniMed into the Aurora organization.

John Knowles

Mr. John L. Knowles serves as Chief Financial Officer, Corporate Secretary, Director of the Company. Mr. Knowles has over 30 years of experience with Canadian and international resource companies and has served as a director, chief executive officer or chief financial officer of more than 10 companies listed on the major Canadian and U.S. stock exchanges. He is a chartered professional accountant and holds a bachelor of commerce from Queen's University.

Gulwant Bajwa

Mr. Gulwant Bajwa serves as Vice President - Business Development and Regulatory Affairs of the Company. Mr. Bajwa joined the Company in December 2015 as Manager, Government Relations and International Business Development. Prior to joining the Company, he was employed with Health Canada as a Senior Program Manager in the former Bureau of Medical Cannabis between January 2011 and September 2014, where he managed the Production and Authorizations and Licensing Divisions. Gulwant was responsible for streamlining the operations of these divisions to restore service standards. Gulwant was awarded the Queen’s Diamond Jubilee Medal, Deputy Minister Award for Creativity and Innovation and two Assistant Deputy Minister Awards for his achievements working in these divisions. Gulwant also worked between 2003 and 2010 as a Policy Analyst in the Intellectual Property and Technology Transfer Office of Health Canada. Before joining the federal public service, Gulwant worked in the private sector, with his last position being Director of Operations at JDS Uniphase Corporation between 1998 and 2003. Gulwant holds a Bachelor’s degree in Social Sciences with specialization in Public Policy and Public Management and Political Science from University of Ottawa and is currently working towards completing his Masters of Business Administration.

Larry Holbrook

Dr. Larry Holbrook serves as Chief Research Officer of the Company. Dr. Holbrook is a senior research scientist and currently Chief Research Officer of the Company, with expertise in cellular and basic molecular biology experimentation and more than 35 years of experience in research and application related to the genetic modification of crop plants with diverse agricultural biotechnology experience in both government and industry. His extensive plant research includes tissue culture, plant breeding, genetic transformation, microscopy, phytohormone and senescence biochemistry. Dr. Holbrook was an associate adjunct professor at the University of Calgary, Department of Biological Sciences from 1997 to 2003 and has authored or co-authored nearly 40 publications, reviews or invited papers in international journals and books. His experience includes leadership roles in four agricultural biotechnology start-up companies in Canada and as a committee member on a North American industry group, BIO, he assisted in developing industry points to consider in white paper proposals for producing plantmade pharmaceuticals (PMPs). He has worked in the medical marijuana field for the past 13 years at the Company leading research developments plus associations with clinical studies initiatives and the QA/QC department functions. Dr. Holbrook holds B.Sc., M.Sc. and a Ph.D. in Neuropharmacology and Developmental Biology from the University of Toronto and postdoctoral research at the UCLA School of Medicine, Brain Research Institute.

Michael Dowty

Mr. Michael Scott Dowty is Director of the Company. Mr. Dowty has over 25 years of experience evaluating companies and markets to identify key business drivers, spur rapid revenue and profit growth, and maximize the value proposition in competitive global markets. Mr. Dowty has held senior executive and corporate officer positions with organizations such as CIBC Card Products, First Data International, Global Cash Access and CardConnect.

Michel Lamontagne

Mr. Michel Lamontagne is Director of the Company. Member of the Quebec bar since 1973, Mr. Lamontagne is an experienced corporate director who serves on the board of directors of a number of companies and organizations in the life sciences, technology and financial sectors. His expertise covers corporate governance, government relations, public affairs, philanthropy and planned giving.

Douglas Banzet

Mr. Douglas W. Banzet serves as Independent Director of the Company. Mr. Banzet is the CFO and Director of Golden Opportunities Fund Inc. and Chief Operating Officer and Director of Westcap Management Ltd. From March 1993 to June 1995, Mr. Banzet was an independent management consultant to a variety of small and medium-sized Saskatchewan businesses. Prior to March 1993, he held various senior management positions with several of large Canadian trust companies. Mr. Banzet has over 40 years of experience in the financial service and asset management fields. His experience includes investment valuations of both private and public businesses, feasibility analysis, risk assessment, commercial loan financing, administration, budgeting, planning and management of large commercial loan portfolios. Mr. Banzet also serves as a Director of a number of private Canadian companies involved in life sciences, oil and gas exploration, biotech, value added processing, health care and service industries.

Rob Duguid

Mr. Rob Duguid serves as Independent Director of the Company. Mr. Duguid is a partner in PFM Capital entities and holds positions of Vice-President, Investments and CFO for the general partner of Prairie Ventures Fund Limited Partnership. He is the Vice President, CFO and Corporate Secretary of SaskWorks Venture Fund Inc., a Director of StorageVault Canada Inc., Vice President Investments, Corporate Secretary and CFO of Saskatchewan Entrepreneurial Fund and of the general partner of Apex Investment Fund.